ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
3.120
+0.130 (4.35%)
Oct 14, 2025, 1:17 PM EDT - Market open
ProKidney Stock Forecast
Stock Price Forecast
The 4 analysts that cover ProKidney stock have a consensus rating of "Strong Buy" and an average price target of $6.25, which forecasts a 100.32% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $9.00.
Price Target: $6.25 (+100.32%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 15, 2025.
Analyst Ratings
The average analyst rating for ProKidney stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 1 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 1 | 1 | 1 | 1 | 0 |
Sell | 0 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 3 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Strong Buy Maintains $4 → $8 | Strong Buy | Maintains | $4 → $8 | +156.41% | Jul 15, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +124.36% | Jul 14, 2025 |
Citigroup | Citigroup | Strong Buy Maintains $6 → $9 | Strong Buy | Maintains | $6 → $9 | +188.46% | Jul 9, 2025 |
B of A Securities | B of A Securities | Hold → Sell Downgrades $3 → $1 | Hold → Sell | Downgrades | $3 → $1 | -67.95% | Jun 30, 2025 |
JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 30, 2024 |
Financial Forecast
Revenue This Year
401.20K
from 76.00K
Increased by 427.89%
Revenue Next Year
106.49K
from 401.20K
Decreased by -73.46%
EPS This Year
-0.53
from -0.62
EPS Next Year
-0.56
from -0.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 764,400 | 548,100 | |||
Avg | 401,197 | 106,488 | |||
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 905.8% | 36.6% | |||
Avg | 427.9% | -73.5% | |||
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.46 | -0.40 | |||
Avg | -0.53 | -0.56 | |||
Low | -0.62 | -0.74 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.